Literature DB >> 22503286

3rd line Erlotinib for lung cancer in Asia may be as cost-effective as in the Western world.

Ching-Chan Lin, Te-Chun Hsia, Chun-Ru Chien.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22503286     DOI： 10.1016/j.lungcan.2012.03.022

Source DB:  PubMed          Journal:  Lung Cancer        ISSN： 0169-5002            Impact factor:   5.705


× No keyword cloud information.
  6 in total

1.  Cost and effectiveness of image-guided radiotherapy for non-operated localized lung cancer: a population-based propensity score-matched analysis.

Authors:  Te-Chun Hsia; Chih-Yen Tu; Hsin-Yuan Fang; Ji-An Liang; Chia-Chin Li; Chun-Ru Chien
Journal:  J Thorac Dis       Date:  2015-09       Impact factor: 2.895

2.  Optimal interval of surgery after neoadjuvant radiochemotherapy in T3-4/N0+ rectal cancer: population level evidence in addition to controlled trial.

Authors:  William Tzu-Liang Chen; Tao-Wei Ke; Yu-Min Liao; Chia-Chin Li; Chun-Ru Chien
Journal:  J Gastrointest Oncol       Date:  2015-06

3.  Cost and effectiveness of video-assisted thoracoscopic surgery for clinical stage I non-small cell lung cancer: a population-based analysis.

Authors:  Hsin-Yuan Fang; Fei-Yuan Hsiao; Hsu-Chih Huang; Yu-Sen Lin; Chih-Yi Chen; Shwn-Huey Shieh; Pin-Ru Chen; Chein-Kuang Chen; Chun-Ru Chien
Journal:  J Thorac Dis       Date:  2014-12       Impact factor: 2.895

4.  Questionable role of adjuvant chemotherapy in rectal cancer patients who had reached pathological complete response after neoadjuvant concurrent chemoradiotherapy: no matter in the East or in the West.

Authors:  William Tzu-Liang Chen; Tao-Wei Ke; Chia-Chin Li; Chun-Ru Chien
Journal:  J Cancer Res Clin Oncol       Date:  2014-06-24       Impact factor: 4.553

5.  Cost-effectiveness of chemotherapy combined with thoracic radiotherapy versus chemotherapy alone for limited stage small cell lung cancer: A population-based propensity-score matched analysis.

Authors:  Chun-Ru Chien; Te-Chun Hsia; Chih-Yi Chen
Journal:  Thorac Cancer       Date:  2014-10-23       Impact factor: 3.500

6.  Cost-effectiveness of neoadjuvant concurrent chemoradiotherapy versus esophagectomy for locally advanced esophageal squamous cell carcinoma: A population-based matched case-control study.

Authors:  Chen-Yuan Lin; Hsin-Yuan Fang; Chun-Lung Feng; Chia-Chin Li; Chun-Ru Chien
Journal:  Thorac Cancer       Date:  2015-12-23       Impact factor: 3.500
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.